Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Debt / NOTE 1.500% 9/1
-
Number of holders
-
14
-
Total 13F principal, excl. options
-
274,717,308
-
Principal change
-
-12,792,195
-
Total reported value, excl. options
-
$277,129,832
-
Value change
-
-$20,916,765,749
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$0.9325
Significant Holders of PTC THERAPEUTICS INC - NOTE 1.500% 9/1 as of Q1 2024
14 filings reported holding 69366JAD3 - PTC THERAPEUTICS INC - NOTE 1.500% 9/1 as of Q1 2024.
PTC THERAPEUTICS INC - NOTE 1.500% 9/1 has 14 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $274,717,308 of principal
.
Largest 10 bondholders include FRANKLIN RESOURCES INC ($63,000,000 of principal), STEELHEAD PARTNERS LLC ($46,300,000 of principal), D. E. Shaw & Co., Inc. ($32,500,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($31,870,000 of principal), DeepCurrents Investment Group LLC ($30,151,000 of principal), Linden Advisors LP ($21,274,000 of principal), WHITEBOX ADVISORS LLC ($17,500,000 of principal), AMERIPRISE FINANCIAL INC ($11,500,000 of principal), Verition Fund Management LLC ($9,503,000 of principal), and READYSTATE ASSET MANAGEMENT LP ($8,227,000 of principal).
This table shows the top 14 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.